Durect Stock (NASDAQ: DRRX) stock price, news, charts, stock research, profile.
Open | $1.130 |
Close | $1.060 |
Volume / Avg. | 100.524K / 156.001K |
Day Range | 1.010 - 1.180 |
52 Wk Range | 0.470 - 7.460 |
Market Cap | $33.208M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 3.02% |
Days to Cover | 6.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.
Other companies in Durect’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).
The latest price target for Durect (NASDAQ: DRRX) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 5.00 expecting DRRX to rise to within 12 months (a possible 371.70% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Durect (NASDAQ: DRRX) is $1.06 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Durect.
Durect’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Durect.
Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.